104 related articles for article (PubMed ID: 2431948)
1. [Relation between serum markers of hepatitis B virus and alpha fetoprotein in hepatocellular carcinoma in France].
Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1986 Oct; 10(10):637-40. PubMed ID: 2431948
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular carcinoma in France. Clinical, biological and virological aspects in 197 patients].
Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1985 May; 9(5):396-402. PubMed ID: 2989069
[TBL] [Abstract][Full Text] [Related]
4. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
8. [Markers of the hepatitis B virus and chronic alcoholism. Prevalence and risk factors].
Renard P; Hillon P; Bedenne L; Fourot M; Milan C; Faivre J; Klepping C
Ann Gastroenterol Hepatol (Paris); 1991; 27(1):7-12. PubMed ID: 1851406
[TBL] [Abstract][Full Text] [Related]
9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and etiologic features of hepatocarcinoma in Sicily].
Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
14. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
Furui J; Furukawa M; Kanematsu T
Hepatogastroenterology; 1995; 42(5):445-9. PubMed ID: 8751193
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma.
Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Ann Surg Oncol; 2007 Nov; 14(11):3181-7. PubMed ID: 17846843
[TBL] [Abstract][Full Text] [Related]
16. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis G virus infection in patients with hepatocellular carcinoma in Recife, Brazil.
Leão-Filho GC; Lopes EP; Ferraz AA; Moura I; Pernambuco JR; Reis C; Silva AE; Ferraz ML
Jpn J Clin Oncol; 2007 Aug; 37(8):632-6. PubMed ID: 17704535
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
